Back
Livento Group Vs. Cidara Therapeutics Sector Stock Comparison
Sell
25
NUGN
Livento Group
Last Price:
$0.0000
Seasonality Move:
15.54%
Buy
69
CDTX
Cidara Therapeutics
Last Price:
$61.97
Seasonality Move:
-9.13%
Sell
25
Livento Group (NUGN)
is a Sell
Is Livento Group a Buy, Sell or Hold?
-
The current Livento Group [NUGN] share price is $0.0020. The Score for NUGN is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
NUGN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
69
Cidara Therapeutics (CDTX)
is a Buy
Is Cidara Therapeutics a Buy, Sell or Hold?
-
The current Cidara Therapeutics [CDTX] share price is $61.93. The Score for CDTX is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
-
CDTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NUGN Stock Price Chart
What is Livento Group's stock price today?
-
The Livento Group share price today is $0.0020Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NUGN is experiencing buying pressure, which is a positive indicator for future bullish movement.
CDTX Stock Price Chart
What is Cidara Therapeutics's stock price today?
-
The Cidara Therapeutics share price today is $61.93Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing slight selling pressure.
NUGN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0 | Buy |
Relative Strength Index (14 RSI): | 48.76 | Sell |
Chaikin Money Flow: | 159042 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
CDTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.94 | Buy |
Relative Strength Index (14 RSI): | 69.23 | Buy |
Chaikin Money Flow: | -31416 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (48.1 - 59.66) | Buy |
Bollinger Bands (100): | (15.54 - 44.42) | Buy |
NUGN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0 | Buy |
20-day SMA: | 0 | Buy |
50-day SMA: | 0 | Sell |
200-day SMA: | 0 | Sell |
8-day EMA: | 0 | Buy |
20-day EMA: | 0 | Buy |
50-day EMA: | 0 | Buy |
200-day EMA: | 0 | Buy |
CDTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 61.58 | Buy |
20-day SMA: | 55.24 | Buy |
50-day SMA: | 39.36 | Buy |
200-day SMA: | 24.51 | Buy |
8-day EMA: | 13.76 | Buy |
20-day EMA: | 5.9 | Buy |
50-day EMA: | 2.43 | Buy |
200-day EMA: | 0.62 | Buy |
Livento Group Earnings Growth & NUGN Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Cidara Therapeutics Earnings Growth & CDTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $3.78 per share, a decrease next quarter of $0.00 per share, an increase this year of $15.76 per share, and a decrease next year of $0.53 per share.
Livento Group Technical Analysis
Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | Jul 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
15 | 16 | 17 | 18 | 21 | 22 | 23 | 24 | 25 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Cidara Therapeutics Technical Analysis
Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | Jul 28 | Jul 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
16 | 17 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |